Kairos Pharma, Ltd. (KAPA)
KAPA Stock Price Chart
Explore Kairos Pharma, Ltd. interactive price chart. Choose custom timeframes to analyze KAPA price movements and trends.
KAPA Company Profile
Discover essential business fundamentals and corporate details for Kairos Pharma, Ltd. (KAPA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Sept 2024
Employees
1.00
Website
https://kairospharma.comCEO
John S. Yu
Description
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.
KAPA Financial Timeline
Browse a chronological timeline of Kairos Pharma, Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.10.
Earnings released on 12 Aug 2025
EPS came in at -$0.08 falling short of the estimated -$0.06 by -33.33%.
Earnings released on 15 Apr 2025
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%.
Earnings released on 26 Feb 2025
EPS came in at -$0.09 falling short of the estimated -$0.06 by -43.82%.
Earnings released on 14 Nov 2024
EPS came in at -$0.10 falling short of the estimated -$0.02 by -400.00%.
Earnings released on 30 Jun 2024
EPS came in at -$0.02 .
Earnings released on 31 Mar 2024
EPS came in at -$0.03 .
Earnings released on 31 Dec 2023
EPS came in at -$0.11 .
Earnings released on 30 Sept 2023
EPS came in at -$0.03 .
Earnings released on 30 Jun 2023
EPS came in at -$0.02 .
Earnings released on 31 Mar 2023
EPS came in at -$0.01 .
Earnings released on 31 Dec 2022
EPS came in at -$0.02 .
Earnings released on 30 Sept 2022
EPS came in at -$0.02 .
Earnings released on 30 Jun 2022
EPS came in at -$0.04 .
Earnings released on 31 Mar 2022
EPS came in at -$0.02 .
KAPA Stock Performance
Access detailed KAPA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.